CHEK1 is a synthetic lethal interactor of FBXO7 in colonic epithelial cells
Colorectal cancer (CRC) remains a leading cause of cancer mortality worldwide, with chromosome instability (CIN) present in approximately 85% of cases and associated with poor prognosis. Reduced expression of FBXO7, a component of the SKP1-CUL1-F-box (SCF) E3 ubiquitin ligase complex, occurs in abou...
Saved in:
| Main Authors: | Tooba Razi, Ally C. Farrell, Rubi Campos Gudiño, Nicole M. Neudorf, Zelda Lichtensztejn, Kirk J. McManus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Molecular Therapy: Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329925000979 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Otsenka effektivnosti i bezopasnosti ispol'zovaniya insulinovykh pomp Accu-Chek
by: Andrey Olegovich Emel'yanov, et al.
Published: (2008-09-01) -
FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
by: Guan Jian, et al.
Published: (2025-08-01) -
FBXO10 Drives Hepatocellular Carcinoma Proliferation via K63-Linked Ubiquitination and Stabilization of FRMPD1
by: Wuguang Liu, et al.
Published: (2025-05-01) -
Ubiquitination and ALL: Identifying FBXO8 as a prognostic biomarker and therapeutic target
by: Wei Xian, et al.
Published: (2025-05-01) -
The role of FOXK2–FBXO32 in breast cancer tumorigenesis: Insights into ribosome‐associated pathways
by: Fuben Liao, et al.
Published: (2025-01-01)